tiprankstipranks
International Stem Cell (ISCO)
OTHER OTC:ISCO
US Market
ISCO
International Stem Cell
RESEARCH TOOLSreports
Want to see ISCO full AI Analyst Report?

International Stem Cell (ISCO) Income Statement

44 Followers

International Stem Cell Income Statement

Last quarter (Q4 2025), International Stem Cell's total revenue was $2.15M, an increase of 1.22% from the same quarter last year. In Q4, International Stem Cell's net income was $-348.00K. See International Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 9.10M$ 9.09M$ 7.79M$ 8.18M$ 7.18M
Gross Profit
$ 5.07M$ 5.32M$ 4.61M$ 4.91M$ 4.24M
Operating Expenses
$ 5.33M$ 5.39M$ 5.27M$ 5.09M$ 6.16M
Depreciation and Amortization
$ 219.00K$ 206.00K$ 194.00K$ 359.00K$ 551.00K
EBITDA
$ -48.00K$ 142.00K$ 202.00K$ 22.00K$ -220.00K
Operating Income
$ -267.00K$ -68.00K$ -663.00K$ -196.00K$ -1.92M
Other Income/Expenses
$ -151.00K$ -141.00K$ 532.00K$ -148.00K$ 1.02M
Pretax Income
$ -418.00K$ -209.00K$ -131.00K$ -331.00K$ -899.00K
Net Income
$ -418.00K$ -209.00K$ -131.00K$ -466.00K$ -1.04M
Per Share Metrics
Basic EPS
$ -0.05$ -0.03$ -0.02$ -0.06$ -0.13
Diluted EPS
$ -0.05$ -0.03$ -0.02$ -0.06$ -0.13
Weighted Average Shares Outstanding
 8.00M 8.00M 8.00M 8.00M 7.83M
Weighted Average Shares Outstanding (Diluted)
 8.00M 8.00M 8.00M 8.00M 7.83M
Currency in USD

International Stem Cell Earnings and Revenue History